341 related articles for article (PubMed ID: 24713888)
1. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
Keefe CC; Goldman MM; Zhang K; Clarke N; Reitz RE; Welt CK
PLoS One; 2014; 9(4):e93805. PubMed ID: 24713888
[TBL] [Abstract][Full Text] [Related]
2. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
[TBL] [Abstract][Full Text] [Related]
3. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
[TBL] [Abstract][Full Text] [Related]
5. Steroid hormone analysis of adolescents and young women with polycystic ovarian syndrome and adrenocortical dysfunction using UPC
Swart AC; du Toit T; Gourgari E; Kidd M; Keil M; Faucz FR; Stratakis CA
Pediatr Res; 2021 Jan; 89(1):118-126. PubMed ID: 32247282
[TBL] [Abstract][Full Text] [Related]
6. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
[TBL] [Abstract][Full Text] [Related]
7. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.
Salameh WA; Redor-Goldman MM; Clarke NJ; Mathur R; Azziz R; Reitz RE
Fertil Steril; 2014 Apr; 101(4):1135-1141.e2. PubMed ID: 24534279
[TBL] [Abstract][Full Text] [Related]
8. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
Rudnicka E; Kunicki M; Radowicki S
Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
[TBL] [Abstract][Full Text] [Related]
9. Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results.
Janse F; Eijkemans MJ; Goverde AJ; Lentjes EG; Hoek A; Lambalk CB; Hickey TE; Fauser BC; Norman RJ
Eur J Endocrinol; 2011 Dec; 165(6):925-33. PubMed ID: 21969522
[TBL] [Abstract][Full Text] [Related]
10. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
Handelsman DJ; Teede HJ; Desai R; Norman RJ; Moran LJ
Hum Reprod; 2017 Feb; 32(2):418-422. PubMed ID: 27999117
[TBL] [Abstract][Full Text] [Related]
11. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
Barth JH; Field HP; Yasmin E; Balen AH
Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
[TBL] [Abstract][Full Text] [Related]
12. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
13. The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis.
Altinkilic EM; du Toit T; Sakin Ö; Attar R; Groessl M; Flück CE
J Steroid Biochem Mol Biol; 2023 Oct; 233():106366. PubMed ID: 37499841
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantitation of four androgens and 17-hydroxyprogesterone in polycystic ovarian syndrome patients by LC-MS/MS.
Cao Z; Lu Y; Cong Y; Liu Y; Li Y; Wang H; Zhang Q; Huang W; Liu J; Dong Y; Tang G; Luo YR; Yin C; Zhai Y
J Clin Lab Anal; 2020 Dec; 34(12):e23539. PubMed ID: 32820576
[TBL] [Abstract][Full Text] [Related]
15. Determination of urinary androgens in women with polycystic ovary syndrome using LC-QqQ/MS and the application of thin film solid-phase microextraction (TF-SPME).
Rajska A; Raczak-Gutknecht J; Struck-Lewicka W; Buszewska-Forajta M; Wityk P; Verding P; Kowalewska A; Siluk D; Rachoń D; Jan Markuszewski M
J Chromatogr A; 2024 Mar; 1718():464735. PubMed ID: 38364619
[TBL] [Abstract][Full Text] [Related]
16. Steroid Hormone Profiling in Hyperandrogenism and Non-hyperandrogenism Women with Polycystic Ovary Syndrome.
Ge J; Yang N; Zhang X; Li M; Zhang W; He J; Zhu H; Cheng X; Shen S; Ge W
Reprod Sci; 2022 Dec; 29(12):3449-3458. PubMed ID: 35835901
[TBL] [Abstract][Full Text] [Related]
17. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
18. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.
Li Y; Zhai Y; Li L; Lu Y; Su S; Liu Y; Xu Z; Xin M; Zhang Q; Cao Z
Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414
[TBL] [Abstract][Full Text] [Related]
19. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
Moran C; Reyna R; Boots LS; Azziz R
Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
[TBL] [Abstract][Full Text] [Related]
20. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Bartoszewicz Z; Kondracka A; Jaźwiec R; Samborowska E; Dadlez M; Wysłouch-Cieszyńska A; Bednarczuk T
Ginekol Pol; 2017; 88(1):5-8. PubMed ID: 28157253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
